JP2018095567A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018095567A5 JP2018095567A5 JP2016238698A JP2016238698A JP2018095567A5 JP 2018095567 A5 JP2018095567 A5 JP 2018095567A5 JP 2016238698 A JP2016238698 A JP 2016238698A JP 2016238698 A JP2016238698 A JP 2016238698A JP 2018095567 A5 JP2018095567 A5 JP 2018095567A5
- Authority
- JP
- Japan
- Prior art keywords
- sugar alcohol
- pharmaceutical composition
- composition according
- hydrogen atom
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000005846 sugar alcohols Chemical class 0.000 claims 7
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- 239000007787 solid Substances 0.000 claims 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 2
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 claims 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 2
- 229930006000 Sucrose Natural products 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 125000004122 cyclic group Chemical group 0.000 claims 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims 2
- 229930195729 fatty acid Natural products 0.000 claims 2
- 239000000194 fatty acid Substances 0.000 claims 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 229930195734 saturated hydrocarbon Natural products 0.000 claims 2
- 229960002920 sorbitol Drugs 0.000 claims 2
- 239000005720 sucrose Substances 0.000 claims 2
- -1 sucrose fatty acid ester Chemical class 0.000 claims 2
- 239000004386 Erythritol Substances 0.000 claims 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims 1
- 235000019414 erythritol Nutrition 0.000 claims 1
- 229940009714 erythritol Drugs 0.000 claims 1
- 229960002870 gabapentin Drugs 0.000 claims 1
- 235000011187 glycerol Nutrition 0.000 claims 1
- 229960005150 glycerol Drugs 0.000 claims 1
- AYXYPKUFHZROOJ-ZETCQYMHSA-N pregabalin Chemical compound CC(C)C[C@H](CN)CC(O)=O AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 claims 1
- 229960001233 pregabalin Drugs 0.000 claims 1
- 239000000600 sorbitol Substances 0.000 claims 1
- 235000010356 sorbitol Nutrition 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016238698A JP7276760B2 (ja) | 2016-12-08 | 2016-12-08 | ４－アミノ－３－ブタン酸類縁体含有固形製剤 |
| JP2023004037A JP2023052398A (ja) | 2016-12-08 | 2023-01-13 | ４－アミノ－３－ブタン酸類縁体含有固形製剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016238698A JP7276760B2 (ja) | 2016-12-08 | 2016-12-08 | ４－アミノ－３－ブタン酸類縁体含有固形製剤 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023004037A Division JP2023052398A (ja) | 2016-12-08 | 2023-01-13 | ４－アミノ－３－ブタン酸類縁体含有固形製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018095567A JP2018095567A (ja) | 2018-06-21 |
| JP2018095567A5 true JP2018095567A5 (enExample) | 2020-01-23 |
| JP7276760B2 JP7276760B2 (ja) | 2023-05-18 |
Family
ID=62631835
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016238698A Active JP7276760B2 (ja) | 2016-12-08 | 2016-12-08 | ４－アミノ－３－ブタン酸類縁体含有固形製剤 |
| JP2023004037A Pending JP2023052398A (ja) | 2016-12-08 | 2023-01-13 | ４－アミノ－３－ブタン酸類縁体含有固形製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023004037A Pending JP2023052398A (ja) | 2016-12-08 | 2023-01-13 | ４－アミノ－３－ブタン酸類縁体含有固形製剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (2) | JP7276760B2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019142834A (ja) * | 2017-07-31 | 2019-08-29 | 大原薬品工業株式会社 | プレガバリン並びに好適な賦形剤を含有する固形製剤 |
| WO2019146642A1 (ja) * | 2018-01-24 | 2019-08-01 | 大原薬品工業株式会社 | γ－アミノ酪酸誘導体含有錠剤の化学的安定性を改善する方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU228772B1 (en) * | 1998-05-15 | 2013-05-28 | Warner Lambert Co | Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same |
| DE102007019071A1 (de) * | 2007-04-23 | 2008-10-30 | Ratiopharm Gmbh | Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin |
| WO2012035559A2 (en) * | 2010-09-17 | 2012-03-22 | Panacea Biotec Ltd | Sustained release pharmaceutical compositions comprising pregabalin |
-
2016
- 2016-12-08 JP JP2016238698A patent/JP7276760B2/ja active Active
-
2023
- 2023-01-13 JP JP2023004037A patent/JP2023052398A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016511753A5 (enExample) | ||
| JP2015078230A5 (enExample) | ||
| JP2014525916A5 (enExample) | ||
| JP2013032389A5 (enExample) | ||
| JP2014129360A5 (enExample) | ||
| JP2015143248A5 (enExample) | ||
| JP2016530259A5 (enExample) | ||
| JP2014218522A5 (enExample) | ||
| JP2014111672A5 (enExample) | ||
| JP2015527386A5 (enExample) | ||
| HRP20160203T1 (hr) | Pripravci koji sadrže 15-hepe i postupci njihove upotrebe | |
| JP2020500916A5 (enExample) | ||
| RU2019138248A (ru) | Фармацевтическая композиция для перорального введения, содержащая энзалутамид | |
| JP2015051983A5 (enExample) | ||
| HK1219222A1 (zh) | 包含降血脂药的制剂 | |
| JP2019516739A5 (enExample) | ||
| JP2011088926A5 (enExample) | ||
| JP2020505440A5 (enExample) | ||
| JP2014505017A5 (enExample) | ||
| JP2016529315A5 (enExample) | ||
| RU2019110980A (ru) | Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением | |
| JP2016510768A5 (enExample) | ||
| JP2015030689A5 (enExample) | ||
| JP2009040767A5 (enExample) | ||
| JP2017505809A5 (enExample) |